- First Quarter Operating Earnings of
$44.2 million ($104.2 million excluding transaction costs),
resulting in an Annualized Operating ROE of 2.9% (6.9% excluding
transaction costs)
- Net Income of $201.4 million ($261.4
million excluding transaction costs), resulting in an Annualized
Net Income ROE of 13.3% (17.3% excluding transaction
costs)
- Total Capital of $7.7 billion, Book
Value of $6.1 billion, and Tangible Book Value of $5.5
billion
PartnerRe Ltd. today reported net income of $201.4 million for
the first quarter of 2016, or an annualized net income ROE of
13.3%. This includes net after-tax realized and unrealized gains on
investments of $148.1 million. Net income for the first quarter of
2015 was $231.7 million, or an annualized net income ROE of 14.8%,
including net after-tax realized and unrealized gains on
investments of $100.3 million. The Company reported operating
earnings of $44.2 million for the first quarter of 2016, or an
annualized operating ROE of 2.9%. This compares to operating
earnings of $150.5 million for the first quarter of 2015, or an
annualized operating ROE of 9.6%.
Operating earnings and net income for the first quarters of 2016
and 2015 include certain after-tax transaction related costs of
$60.0 million and $30.9 million, respectively. Adjusting for these
after-tax transaction related costs, the annualized operating ROE
for the first quarters of 2016 and 2015 was 6.9% and 11.6%,
respectively, and the annualized net income ROE for the first
quarters of 2016 and 2015 was 17.3% and 16.8%, respectively.
Operating earnings or loss excludes certain net after-tax
realized and unrealized investment gains and losses, net after-tax
foreign exchange gains and losses, certain net after-tax interest
in results of equity method investments, and is calculated after
the payment of preferred dividends.
Commenting on results, PartnerRe Chief Executive Officer
Emmanuel Clarke said, “We had a solid start to 2016 that culminated
with the closing of the EXOR acquisition, which lands us on solid
ground and enables us to move forward with our usual focus and
determination. Our performance for the quarter resulted in an
operating ROE of 6.9%, which reflects continuing difficult
conditions across nearly all reinsurance markets, an absence of
major catastrophes and continued favorable reserve development.
With our new ownership now set, we look forward to leveraging our
strong franchise and serving as a preferred reinsurer to our
clients.”
Highlights for the first quarter of 2016 compared to the same
period in 2015 include:
Results of operations:
- Net premiums written of $1.5 billion
were down 9%. On a constant foreign exchange basis, net premiums
written were down 5% with decreases recorded in all Non-life
sub-segments, with the exception of the North America sub-segment,
and the Life and Health segment.
- Net premiums earned of $1.1 billion
were down 8%. On a constant foreign exchange basis, net premiums
earned were down 4% due to the same factors described above for net
premiums written.
- The Non-life combined ratio was 94.3%.
The combined ratio benefited from favorable prior year development
of 21.0 points (or $183 million). All Non-life sub-segments
experienced net favorable development from prior accident years
during the first quarter of 2016.
- For the first quarter of 2016, other
expenses of $153 million include $66 million, pre-tax, of costs
related to the closing of the Exor transaction (including the
impact of accelerating all remaining share based compensation
expense as a result of all awards vesting upon closing). Other
expenses of $125 million for the same period in 2015 included $31
million, pre-tax, of costs related to the terminated amalgamation
with Axis.
- Net investment income of $103 million
was down 2%. On a constant foreign exchange basis, net investment
income was up 1%.
- Pre-tax net realized and unrealized
investment gains were $167 million, primarily reflecting decreases
in U.S. and European risk-free interest rates.
- The effective tax rate on operating
earnings and non-operating earnings was 23.6% and 7.6%,
respectively.
Balance sheet and capitalization:
- Total investments, cash and funds held
– directly managed were $16.2 billion at March 31, 2016, down
2% compared to December 31, 2015, primarily due to cash
outflows to fund the special dividend (as defined below) and the
settlement of certain share based awards upon the closing of the
Exor transaction.
- Net Non-life loss and loss expense
reserves were $9.1 billion at March 31, 2016, up 3% compared
to December 31, 2015, primarily reflecting lower losses paid
and the impact of foreign exchange.
- Net policy benefits for life and
annuity contracts were $2.0 billion at March 31, 2016, up 2%
compared to December 31, 2015, primarily reflecting lower
losses paid and the impact of foreign exchange.
- Total capital was $7.7 billion at
March 31, 2016, which was flat compared to December 31,
2015, with net income for the quarter being offset by common and
preferred share dividend payments (including the special dividend
(as defined below) paid on the closing of the Exor
transaction).
- Common shareholders' equity
attributable to PartnerRe (or book value) and tangible book value
were $6.1 billion and $5.5 billion, respectively, at March 31,
2016, which were flat compared to December 31, 2015 due to the
same factors as for total capital.
Segment and sub-segment highlights for the first quarter of 2016
compared to the same period in 2015 include:
Non-life:
- The Non-life segment’s net premiums
written were down 9%, or 5% on a constant foreign exchange basis.
The decrease was driven by the Global (Non-U.S.) P&C and
Catastrophe sub-segments and, to a lesser extent, the Global
Specialty sub-segment. These decreases were partially offset by an
increase in the net premiums written reported by the North America
sub-segment.
- The North America sub-segment’s net
premiums written were up 2%, or 3% on a constant foreign exchange
basis. The increase was primarily driven by the timing of renewals
in the agriculture and casualty lines of business, and new business
in the casualty and structured property lines of business. These
increases were partially offset by cancellations, downward prior
year premium adjustments and renewal changes in the casualty,
property and agriculture lines of business, and the impact of
increased retrocessional coverage in the mortgage line of business.
This sub-segment reported a technical ratio of 86.9%, which
included 22.9 points (or $81 million) of net favorable prior year
loss development.
- The Global (Non-U.S.) P&C
sub-segment’s net premiums written were down 19%, or 11% on a
constant foreign exchange basis. The decrease was primarily driven
by downward prior year premium adjustments and cancellations, and
reduced participations in the motor line of business. This
sub-segment reported a technical ratio of 113.2%, which included
15.5 points (or $23 million) of net favorable prior year loss
development.
- The Global Specialty sub-segment’s net
premiums written were down 8%, or 3% on a constant foreign exchange
basis. The decrease was driven by cancellations, reduced
participations, and higher downward prior year premium adjustments
across multiple lines of business. These decreases were partially
offset by new business written across all lines of business and the
positive impact of a timing difference related to the renewal of a
significant specialty casualty treaty. This sub-segment reported a
technical ratio of 85.0%, which included 21.4 points (or $69
million) of net favorable prior year loss development.
- The Catastrophe sub-segment’s net
premiums written were down 20%, or 16% on a constant foreign
exchange basis. The decrease was primarily driven by increased
retrocessional coverage, timing of renewals, cancellations and
non-renewals. These decreases were partially offset by new
business. This sub-segment reported a technical ratio of 10.3%,
which included 22.0 points (or $10 million) of net favorable prior
year loss development.
Life and Health:
- The Life and Health segment’s net
premiums written were down 12%, or 7% on a constant foreign
exchange basis. The decrease was driven by downward prior year
premium adjustments and non-renewals in the mortality line of
business and increased client retentions in the Health line of
business.
- The Life and Health segment’s allocated
underwriting result, which includes allocated investment income and
other expenses, was $24 million compared to $25 million in the same
period of 2015, and includes $15 million of favorable prior year
loss development compared to $14 million in the same period of
2015.
The Company has posted its first quarter 2016 financial
supplement on its website www.partnerre.com in the Financial
Information section of the Investor Relations page under
Supplementary Financial Data, which includes a reconciliation of
GAAP and non-GAAP measures.
_________________________________________
On March 18, 2016, EXOR acquired 100% ownership of the Company's
common shares. Pursuant to the terms of the Merger Agreement, each
PartnerRe common share issued and outstanding immediately prior to
the effective time of the Merger was cancelled and converted into
$137.50 in cash per share and entitled to receive a one-time
special pre-closing cash dividend in the amount of $3.00 per common
share (special dividend). One common share at $1.00 par value was
issued to Exor N.V., representing 100% common share ownership of
the Company. Accordingly, all net income per share, operating
earnings per share and book value per share data for the current
year and the prior year periods is no longer considered meaningful
and has been excluded. The Company also redefined its calculation
of Annualized Operating ROE to be based on average common
shareholders' equity, accordingly, all comparative data has been
recast.
Net income/loss attributable to PartnerRe common shareholders is
defined as net income/loss attributable to PartnerRe less preferred
dividends.
Operating earnings/loss is defined as net income/loss available
to PartnerRe common shareholders excluding certain after-tax net
realized and unrealized gains/losses on investments, after-tax net
foreign exchange gains/losses, certain after-tax interest in
earnings/losses of equity method investments and the amalgamation
termination fee and reimbursement of expenses paid to Axis Capital
(included in other expenses).
The Company uses operating earnings and annualized operating
return on average common shareholders' equity (Annualized Operating
ROE) to measure performance, as these measures focus on the
underlying fundamentals of our operations without the impact of
after-tax net realized and unrealized gains/losses on investments
(except where the Company has made a strategic investment in an
insurance or reinsurance related investee), after-tax net foreign
exchange gains/losses, the after-tax interest in earnings/losses of
equity method investments (except where the Company has made a
strategic investment in an insurance or reinsurance related
investee and where the Company does not control the investees
activities), and the amalgamation termination fee and reimbursement
of expenses paid to Axis Capital (included in other expenses).
The Company calculates annualized operating return on average
common shareholders' equity using operating earnings (loss) for the
period divided by the average common shareholders' equity
outstanding for the period.
The Company uses technical ratio and technical result as
measures of underwriting performance. The technical ratio is
defined as the sum of the loss and acquisition ratios. These
metrics exclude other expenses.
The Company also uses combined ratio to measure results for the
Non-life segment. The combined ratio is the sum of the technical
and other expense ratios.
The Company uses allocated underwriting result as a measure of
underwriting performance for its Life and Health operations. This
metric is defined as net premiums earned, other income or loss and
allocated net investment income less life policy benefits,
acquisition costs and other expenses.
The Company uses total capital, which is defined as total
shareholders’ equity attributable to PartnerRe, long-term debt,
senior notes and CENts, to manage the capital structure of the
Company.
_____________________________________________
PartnerRe Ltd. is a leading global reinsurer, providing
multi-line reinsurance to insurance companies. The Company, through
its wholly owned subsidiaries, also offers capital markets products
that include weather and credit protection to financial, industrial
and service companies. Risks reinsured include property, casualty,
motor, agriculture, aviation/space, catastrophe, credit/surety,
engineering, energy, marine, specialty property, specialty
casualty, multi-line and other lines in its Non-life operations,
mortality, longevity and accident and health in its Life and Health
operations, and alternative risk products. For the year ended
December 31, 2015, total revenues were $5.4 billion. At
March 31, 2016, total assets were $22.0 billion, total capital
was $7.7 billion and total shareholders’ equity attributable to
PartnerRe was $6.9 billion.
PartnerRe on the Internet: www.partnerre.com
Forward-looking statements contained in this press release
are based on the Company’s assumptions and expectations concerning
future events and financial performance and are made pursuant to
the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Such statements are subject to significant
business, economic and competitive risks and uncertainties that
could cause actual results to differ materially from those
reflected in the forward-looking statements. PartnerRe’s
forward-looking statements could be affected by numerous
foreseeable and unforeseeable events and developments such as
exposure to catastrophe, or other large property and casualty
losses, credit, interest, currency and other risks associated with
the Company’s investment portfolio, adequacy of reserves, levels
and pricing of new and renewal business achieved, changes in
accounting policies, risks associated with implementing business
strategies, and other factors identified in the Company’s filings
with the Securities and Exchange Commission. In light of the
significant uncertainties inherent in the forward-looking
information contained herein, readers are cautioned not to place
undue reliance on these forward-looking statements, which speak
only as of the dates on which they are made. The Company disclaims
any obligation to publicly update or revise any forward-looking
information or statements.
PartnerRe Ltd.
Consolidated Statements of Operations
and Comprehensive Income (1)
(Expressed in thousands of U.S.
dollars)
(Unaudited)
For the three
For the three
months ended
months ended
March 31,
March 31,
2016
2015
Revenues Gross premiums written
$ 1,629,009
$ 1,748,933 Net premiums written
$
1,500,718 $ 1,653,215 Increase in unearned premiums
(359,002 ) (418,493 ) Net premiums earned
1,141,716 1,234,722 Net investment income
102,987
104,631 Net realized and unrealized investment gains
167,193
115,645 Other income
4,840 4,292
Total
revenues 1,416,736 1,459,290
Expenses Losses and loss expenses and life policy benefits
714,268 721,281 Acquisition costs
282,974 275,791
Other expenses (2)
152,674 124,750 Interest expense
12,259 12,245 Amortization of intangible assets
6,588
6,768 Net foreign exchange gains
(2,074 ) (13,147 )
Total expenses 1,166,689 1,127,688
Income before taxes and interest in losses of equity method
investments 250,047 331,602 Income tax expense
30,954 79,665 Interest in losses of equity method
investments
(3,467 ) (3,838 )
Net income
215,626 248,099 Net income attributable to noncontrolling
interests
— (2,182 )
Net income attributable to
PartnerRe 215,626 245,917 Preferred dividends
14,184 14,184
Net income attributable to
PartnerRe common shareholders $ 201,442 $
231,733
Operating earnings attributable to PartnerRe
common shareholders (2) $ 44,238 $
150,536
Comprehensive income attributable to
PartnerRe $ 235,717 $ 242,760
(1) On March 18, 2016 EXOR acquired 100%
ownership of the Company; as such, per share data is no longer
meaningful and has been excluded.
(2) Other expenses and operating earnings
for the three months ended March 31, 2016 include $35 million and
$31 million of transaction costs and accelerated stock based
compensation expense, respectively, related to the closing of the
Exor transaction, pre-tax. Other expenses and operating earnings
for the three months ended March 31, 2015 include $31 million of
costs related to the proposed amalgamation with Axis, pre-tax.
PartnerRe Ltd.
Consolidated Balance Sheets
(1)
(Expressed in thousands of U.S. dollars,
except parenthetical share data)
(Unaudited)
March 31, December 31,
2016 2015
Assets Investments: Fixed maturities, at fair value
$ 13,020,014 $ 13,448,262 Short-term investments, at
fair value
33,555 46,688 Equities, at fair value
324,427 443,861 Other invested assets
458,709
399,204
Total investments 13,836,705
14,338,015 Funds held – directly managed
579,571 539,743
Cash and cash equivalents
1,749,851 1,577,097 Accrued
investment income
134,735 141,672 Reinsurance balances
receivable
2,964,950 2,428,020 Reinsurance recoverable on
paid and unpaid losses
300,731 282,916 Funds held by
reinsured companies
685,564 657,815 Deferred acquisition
costs
691,117 629,372 Deposit assets
82,018 88,152
Net tax assets
82,405 102,596 Goodwill
456,380
456,380 Intangible assets
126,423 133,011 Other assets
265,013 31,254
Total assets $
21,955,463 $ 21,406,043
Liabilities
Unpaid losses and loss expenses
$ 9,331,087 $
9,064,711 Policy benefits for life and annuity contracts
2,089,055 2,051,935 Unearned premiums
2,086,332
1,644,757 Other reinsurance balances payable
293,342 246,089
Deposit liabilities
33,506 44,420 Net tax liabilities
197,973 218,652 Accounts payable, accrued expenses and other
192,994 411,539 Debt related to senior notes
750,000
750,000 Debt related to capital efficient notes
70,989
70,989
Total liabilities 15,045,278
14,503,092
Shareholders’ Equity Common shares
(par value $1.00; issued: 2016, 1 share and 2015, 87,237,220
shares)
— 87,237 Preferred shares (par value $1.00; issued
and outstanding: 2016 and 2015, 34,150,000 shares; aggregate
liquidation value: 2016 and 2015, $853,750)
34,150 34,150
Additional paid-in capital
2,537,359 3,982,147 Accumulated
other comprehensive loss
(63,192 ) (83,283 ) Retained
earnings
4,401,868 6,146,802 Common shares held in treasury,
at cost (2016, nil shares; 2015, 39,303,068 shares)
—
(3,266,552 )
Total shareholders’ equity attributable to
PartnerRe 6,910,185 6,900,501 Noncontrolling interests
— 2,450
Total shareholders’ equity
6,910,185 6,902,951
Total liabilities and
shareholders’ equity $ 21,955,463 $
21,406,043
(1) On March 18, 2016 EXOR acquired 100%
ownership of the Company; as such, per share data is no longer
meaningful and has been excluded.
PartnerRe Ltd.
Segment Information
(Expressed in millions of U.S.
dollars)
(Unaudited)
For the three months ended March 31, 2016
Global
Total
Life
North
(Non-U.S.)
Global
Non-life
and Health
Corporate
America
P&C
Specialty
Catastrophe
segment
segment
and Other
Total Gross premiums written $ 494 $ 274 $ 398 $ 170 $ 1,336
$ 293 $ — $ 1,629 Net premiums written $ 481 $ 269 $ 333 $ 141 $
1,224 $ 277 $ — $ 1,501 Increase in unearned premiums (129 ) (119 )
(11
) (93 ) (352 ) (7 ) — (359 ) Net premiums earned $ 352 $ 150
$ 322 $ 48 $ 872 $ 270 $ — $ 1,142 Losses and loss expenses and
life policy benefits (199 ) (123 ) (184 ) (3 ) (509 ) (205 ) — (714
) Acquisition costs (107 ) (47 ) (90 ) (1 ) (245 ) (38 ) —
(283 )
Technical result $ 46 $
(20 ) $ 48 $ 44 $
118 $ 27 $ — $ 145
Other income 2 2 1 5 Other expenses (68 ) (18 ) (67 ) (153 )
Underwriting result $ 52 $ 11
n/a $ (3 ) Net investment income 13
90 103
Allocated underwriting result
(1) $ 24 n/a n/a Net realized
and unrealized investment gains 167 167 Interest expense (12 ) (12
) Amortization of intangible assets (7 ) (7 ) Net foreign exchange
gains 2 2 Income tax expense (31 ) (31 ) Interest in losses of
equity method investments (3 ) (3 )
Net income n/a
$ 216 Loss ratio (2) 56.5 % 82.1 % 57.2 % 7.2
% 58.5 % Acquisition ratio (3) 30.4 31.1 27.8
3.1 28.0 Technical ratio (4) 86.9 % 113.2 % 85.0 %
10.3 % 86.5 % Other expense ratio (5) 7.8 Combined ratio (6)
94.3 %
For the three months ended March 31, 2015
Global
Total
Life
North
(Non-U.S.)
Global
Non-life
and Health
Corporate
America
P&C
Specialty
Catastrophe
segment
segment
and Other
Total Gross premiums written $ 473 $ 334 $ 427 $ 191 $ 1,425
$ 324 $ — $ 1,749 Net premiums written $ 471 $ 331 $ 362 $ 176 $
1,340 $ 313 $ — $ 1,653 (Increase) decrease in unearned premiums
(132 ) (157 ) 3 (118 ) (404 ) (14 ) — (418 ) Net
premiums earned $ 339 $ 174 $ 365 $ 58 $ 936 $ 299 $ — $ 1,235
Losses and loss expenses and life policy benefits (172 ) (119 )
(170 ) (20 ) (481 ) (240 ) — (721 ) Acquisition costs (93 ) (52 )
(93 ) (4 ) (242 ) (34 ) — (276 )
Technical result
$ 74 $ 3 $ 102 $
34 $ 213 $ 25 $ —
$ 238 Other income — 1 3 4 Other expenses (52 ) (15 )
(58 ) (125 )
Underwriting result $ 161
$ 11 n/a $ 117 Net investment
income 14 91 105
Allocated underwriting
result (1) $ 25 n/a n/a Net
realized and unrealized investment gains 116 116 Interest expense
(12 ) (12 ) Amortization of intangible assets (7 ) (7 ) Net foreign
exchange gains 13 13 Income tax expense (80 ) (80 ) Interest in
losses of equity method investments (4 ) (4 )
Net income
n/a $ 248 Loss ratio (2) 50.7 % 68.4 %
46.7 % 33.7 % 51.4 % Acquisition ratio (3) 27.5 30.1
25.4 7.0 25.9 Technical ratio (4) 78.2 % 98.5
% 72.1 % 40.7 % 77.3 % Other expense ratio (5) 5.5 Combined
ratio (6) 82.8 %
(1) Allocated underwriting result is
defined as net premiums earned, other income or loss and allocated
net investment income less life policy benefits, acquisition costs
and other expenses.
(2) Loss ratio is obtained by dividing
losses and loss expenses by net premiums earned.
(3) Acquisition ratio is obtained by
dividing acquisition costs by net premiums earned.
(4) Technical ratio is defined as the sum
of the loss ratio and the acquisition ratio.
(5) Other expense ratio is obtained by
dividing other expenses by net premiums earned.
(6) Combined ratio is defined as the sum
of the technical ratio and the other expense ratio.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160502005757/en/
PartnerRe Ltd.441-292-0888Investors: Robin SiddersMedia:
Celia PowellorSard Verbinnen & Co212-687-8080Drew
Brown/Robin Weinberg
Partnerre (NYSE:PRE)
過去 株価チャート
から 11 2024 まで 12 2024
Partnerre (NYSE:PRE)
過去 株価チャート
から 12 2023 まで 12 2024